As Chicagoland prepares to host the world’s largest biotech convention, new data reveals the strength of the state’s innovation pipeline, according to the new Illinois Biotechnology Innovation Organization (iBIO) Member Investor Portfolio Report.
The numbers tell a compelling story: nearly 100 life science companies in Illinois raised over $1.24 billion in venture-style investments during 2024, demonstrating remarkable resilience in a challenging funding environment.
The bottom line: Illinois combines top-tier funding, infrastructure, talent, and innovation—making it a smart bet for biotech and health innovation and growing life science companies.